27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Siglecg Limits the Size of B1a B Cell Lineage by Down-Regulating NFκB Activation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          B1 B cells are believed to be a unique lineage with a distinct developmental pathway, function and activation requirement. How this lineage is genetically determined remained largely obscure.

          Methods and Principal Findings

          Using the Siglecg-deficient mice with a knockin of green-fluorescent protein encoding sequence, we show here that, although the Siglecg gene is broadly expressed at high levels in all stages and/or lineages of B cells tested and at lower levels in other lineages, its deletion selectively expanded the B1a B cell lineages, including the frequency of the B1 cell progenitor in the bone marrow and the number of B1a cells in the peritoneal cavity, by postnatal expansion. The expansion of B1a B cells in the peritoneal correlated with enhanced activation of NFκB and was ablated by an IKK inhibitor.

          Conclusion and Significance

          Our data revealed a critical role for Siglec G-NFκB pathway in regulating B1a B cell lineage. These data lead to a novel model of B1a lineage development that explains a large array of genetic data in this field.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          B cell development pathways.

          B cell development is a highly regulated process whereby functional peripheral subsets are produced from hematopoietic stem cells, in the fetal liver before birth and in the bone marrow afterward. Here we review progress in understanding some aspects of this process in the mouse bone marrow, focusing on delineation of the earliest stages of commitment, on pre-B cell receptor selection, and B cell tolerance during the immature-to-mature B cell transition. Then we note some of the distinctions in hematopoiesis and pre-B selection between fetal liver and adult bone marrow, drawing a connection from fetal development to B-1/CD5(+) B cells. Finally, focusing on CD5(+) cells, we consider the forces that influence the generation and maintenance of this distinctive peripheral B cell population, enriched for natural autoreactive specificities that are encoded by particular germline V(H)-V(L) combinations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.

            Clonogenic multipotent mouse hematopoietic stem cells (HSCs) and progenitor cells are contained within the c-kit(+) (K) lineage(-/lo) (L) Sca-1(+) (S) population of hematopoietic cells; long-term (LT) and short-term (ST) HSCs are Thy-1.1(lo). c-kit is a member of the receptor tyrosine kinase family, a class of receptors that are important in the proliferation and differentiation of hematopoietic cells. To establish whether the Flk-2/Flt3 receptor tyrosine kinase was expressed on the most primitive LT-HSCs, we sorted highly purified multipotent stem and progenitor cells on the basis of Flk-2 surface expression and used them in competitive reconstitution assays. Low numbers of Flk-2(-) HSCs gave rise to long-term multilineage reconstitution in the majority of recipients, whereas the transfer of Flk-2(+) multipotent cells resulted in mostly short-term multilineage reconstitution. The KLS subset of adult mouse bone marrow was analyzed for Flk-2 and Thy-1.1 expression. Three phenotypically and functionally distinct populations were isolated: Thy(lo) Flk-2(-) (LT-HSCs), Thy(lo) Flk-2(+) (ST-HSCs), and Thy(-) Flk-2(+) multipotent progenitors. The loss of Thy-1.1 and gain of Flk-2 expression marks the loss of self-renewal in HSC maturation. The addition of Flk-2 antibody to the lineage mix allows direct isolation of LT-HSC from adult bone marrow as c-kit(+) lin(-) Sca-1(+) Flk-2(-) from many strains of mice. Fetal liver HSCs are contained within Flk-2(-) and Flk-2(+) KTLS cells.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.

              Advanced breast cancers frequently metastasize to bone, resulting in osteolytic lesions, yet the underlying mechanisms are poorly understood. Here we report that nuclear factor-kappaB (NF-kappaB) plays a crucial role in the osteolytic bone metastasis of breast cancer by stimulating osteoclastogenesis. Using an in vivo bone metastasis model, we found that constitutive NF-kappaB activity in breast cancer cells is crucial for the bone resorption characteristic of osteolytic bone metastasis. We identified the gene encoding granulocyte macrophage-colony stimulating factor (GM-CSF) as a key target of NF-kappaB and found that it mediates osteolytic bone metastasis of breast cancer by stimulating osteoclast development. Moreover, we observed that the expression of GM-CSF correlated with NF-kappaB activation in bone-metastatic tumor tissues from individuals with breast cancer. These results uncover a new and specific role of NF-kappaB in osteolytic bone metastasis through GM-CSF induction, suggesting that NF-kappaB is a potential target for the treatment of breast cancer and the prevention of skeletal metastasis.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS ONE
                plos
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2007
                3 October 2007
                : 2
                : 10
                : e997
                Affiliations
                [1 ]Division of Immunotherapy, Section of General Surgery, Department of Surgery, University of Michigan School of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America
                [2 ]Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan School of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America
                [3 ]Program of Molecular Mechanism of Diseases and Comprehensive Cancer Center, University of Michigan School of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America
                [4 ]Department of Pathology, University of Michigan School of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America
                [5 ]Laboratory of Molecular Signaling and Apoptosis, School of Dentistry, University of California at Los Angeles, Los Angeles, California, United States of America
                [6 ]Integrated Biomedical Graduate Program, The Ohio State University, Columbus, Ohio, United States of America
                Washington University, United States of America
                Author notes
                * To whom correspondence should be addressed. E-mail: panz@ 123456umich.edu (PZ); yangl@ 123456umich.edu (YL)

                Conceived and designed the experiments: PZ Yang L CD CW. Performed the experiments: CD Yan L YW BP. Analyzed the data: PZ Yang L CD CW. Wrote the paper: PZ Yang L CD.

                Article
                07-PONE-RA-02080R1
                10.1371/journal.pone.0000997
                1994585
                17912374
                47f95b8b-1da4-425e-a7b0-757b01bcf863
                Ding et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                History
                : 24 August 2007
                : 17 September 2007
                Page count
                Pages: 10
                Categories
                Research Article
                Genetics and Genomics
                Genetics and Genomics/Genetics of the Immune System

                Uncategorized
                Uncategorized

                Comments

                Comment on this article